Iovance Biotherapeutics, Nio, NetEase And Other Big Stocks Moving Lower On Wednesday

U.S. stocks traded mostly higher, with the Dow Jones index gaining around 80 points on Wednesday.

Shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) fell sharply during Wednesday’s session after the company announced a clinical program update for LN-145 TIL therapy in non-small lung cancer (NSCLC).

The FDA placed a clinical hold on the IOV-LUN-202 trial on December 22, 2023, in response to a recently reported Grade 5 (fatal) serious adverse event potentially related to the non-myeloablative lymphodepletion pre-conditioning regimen.
Iovance Biotherapeutics shares dipped 20.4% to $7.07 on Wednesday.

Here are some other big stocks recording gains in today’s session.

 

Now Read This: Ethereum Moves Higher; Bitcoin SV Emerges As Top Gainer

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.